Related Experiment Video
Updated: Apr 26, 2026
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Patient experiences with intrathecal baclofen as a treatment for spasticity - a pilot study
Stina Gunnarsson1, Kersti Samuelsson
1Department of Rehabilitation Medicine and Department of Medicine and Health Sciences, Linköping University , Linköping , Sweden.
Purpose:
This study describes how patients experience intrathecal baclofen (ITB) treatment.
Methods:
Data were collected from interviews with 14 patients (19-76 years old) who were diagnosed with spinal cord injury (SCI), multiple sclerosis (MS), or cerebral palsy (CP). Data were analyzed using conventional content analysis.
Result:
The analysis resulted in 16 subcategories arranged into five main categories: procedures before treatment, the effect of ITB on daily life and activities, continuous follow-up, expected and unexpected consequences of ITB, and overall level of satisfaction with ITB. Together these categories described the patients' experiences with ITB treatment. When the patients were asked whether they would undergo ITB again, they all stated that they would.
Conclusion:
Patients stated that they were highly satisfied with the ITB treatment. However, the patients identified several areas that could be improved. Specifically, the patients wanted more information about the different steps in the treatment process and what to expect from ITB treatment.
